IBM Expands Its Hybrid Cloud and AI Capabilities with CockroachDB Integration

Earlier today, Cockroach Labs announced that its main product, CockroachDB, will now support tech company IBM’s (IBM) LinuxONE and IBM Z systems, which use the s390x processor. This will bring CockroachDB’s ability to scale and handle data across multiple systems to some of the most secure and reliable platforms used by big industries. IBM customers can now use CockroachDB alongside their existing systems for hybrid cloud and AI projects. This is especially helpful for highly regulated industries like banking and healthcare, where security and compliance are very important.

Interestingly, CockroachDB is built to manage critical tasks without interruptions. Indeed, its system copies data across many servers, so even if some servers go down, the system keeps running. Running CockroachDB on IBM’s architecture improves this even more by adding IBM’s strong security and performance features. This makes it a good fit for important jobs like processing payments or managing user accounts. Developers can also use CockroachDB’s PostgreSQL-compatible interface and easily scale across IBM systems as demand grows.

On top of reliability and scalability, CockroachDB also offers flexibility and strong security by working across both on-site servers and cloud environments. This lets businesses store data where it makes the most sense without extra work. In addition, running on IBM’s platforms adds powerful encryption and secure key management capabilities, which further protect sensitive data. Cockroach Labs said this partnership with IBM fits into its plan to help companies modernize their operations while keeping important data safe and always available.

What Is the Target Price for IBM?

Turning to Wall Street, analysts have a Moderate Buy consensus rating on IBM stock based on eight Buys, five Holds, and two Sells assigned in the past three months, as indicated by the graphic below. Furthermore, the average IBM price target of $258.79 per share implies 2.7% upside potential.

See more IBM analyst ratings